Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Homo sapiens | TAR DNA binding protein | Starlite/ChEMBL | No references |
Homo sapiens | lamin A/C | Starlite/ChEMBL | No references |
Homo sapiens | thyroid hormone receptor, beta | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | photoreceptor-specific nuclear receptor | thyroid hormone receptor, beta | 461 aa | 414 aa | 24.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.3758 | 1 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.1082 | 0.2802 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0607 | 0.4015 |
Loa Loa (eye worm) | intermediate filament protein | 0.0033 | 0.0387 | 0.2561 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1095 | 0.724 |
Echinococcus multilocularis | Mitotic checkpoint protein PRCC, C terminal | 0.0152 | 0.3446 | 0.3419 |
Schistosoma mansoni | lamin | 0.0033 | 0.0387 | 0.0931 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1095 | 0.724 |
Echinococcus multilocularis | lamin | 0.0033 | 0.0387 | 0.0348 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1095 | 0.724 |
Loa Loa (eye worm) | RNA binding protein | 0.0076 | 0.1512 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0152 | 0.3446 | 0.9159 |
Echinococcus granulosus | lamin | 0.0033 | 0.0387 | 0.0348 |
Brugia malayi | TAR-binding protein | 0.0076 | 0.1512 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.0041 | 0.0271 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0607 | 0.1523 |
Onchocerca volvulus | 0.006 | 0.1082 | 1 | |
Echinococcus granulosus | lamin dm0 | 0.0033 | 0.0387 | 0.0348 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0076 | 0.1512 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1512 | 0.3957 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0387 | 0.2561 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0607 | 0.4015 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1095 | 0.724 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.0041 | 0.0271 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0076 | 0.1512 | 1 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0033 | 0.0387 | 0.2561 |
Echinococcus multilocularis | lamin dm0 | 0.0033 | 0.0387 | 0.0348 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1512 | 0.3957 |
Schistosoma mansoni | lamin | 0.0033 | 0.0387 | 0.0931 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1512 | 0.3957 |
Brugia malayi | intermediate filament protein | 0.0033 | 0.0387 | 0.2561 |
Brugia malayi | RNA binding protein | 0.0076 | 0.1512 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.0041 | 0.0271 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0033 | 0.0387 | 0.2561 |
Echinococcus granulosus | intermediate filament protein | 0.0033 | 0.0387 | 0.0348 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.0041 | 0.0271 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1512 | 0.3957 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0372 | 0.246 |
Echinococcus multilocularis | tar DNA binding protein | 0.0076 | 0.1512 | 0.1477 |
Echinococcus granulosus | tar DNA binding protein | 0.0076 | 0.1512 | 0.1477 |
Echinococcus granulosus | Mitotic checkpoint protein PRCC C terminal | 0.0152 | 0.3446 | 0.3419 |
Loa Loa (eye worm) | TAR-binding protein | 0.0076 | 0.1512 | 1 |
Schistosoma mansoni | thyroid hormone receptor | 0.0164 | 0.3758 | 1 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0076 | 0.1512 | 0.3957 |
Schistosoma mansoni | intermediate filament proteins | 0.0033 | 0.0387 | 0.0931 |
Echinococcus multilocularis | thyroid hormone receptor alpha | 0.0164 | 0.3758 | 0.3732 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1082 | 0.716 |
Echinococcus multilocularis | musashi | 0.0033 | 0.0387 | 0.0348 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.0158 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 7.9433 um | PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 89.1251 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.